Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex

Annals of Neurology

Volumn 48, Issue 3, 2000, Pages 391-395

  Kuhl, David E ^a,b   Minoshima, Satoshi ^a   Frey, Kirk A ^a   Foster, Norman L ^a   Kilbourn, Michael R ^a   Koeppe, Robert A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; PHYSOSTIGMINE SALICYLATE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG UTILIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IMMUNOCYTOCHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; HUMANS; INDANS; MIDDLE AGED; PHYSOSTIGMINE; PIPERIDINES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033844518     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H     Document Type: Article

References (17)

1. The cholinergic hypothesis of Alzheimer's disease: A review of progress
2. Doody blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
3. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
4. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
5. A new clinical scale for the staging of dementia
6. 'Mini Mental State': A practical method for grading the cognitive state of patients for the clinician
7. 11C]PMP) for in vivo measurements of acetylcholinesterase activity
8. 18F]FDG
9. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease
10. Neurotransmitter changes in Alzheimer's disease: Implications to diagnostics and therapy
11. In vivo imaging of cholinergic terminals in normal aging, Alzheimer's disease and Parkinson's disease
12. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo
13. Changes in brain cholinesterase in senile dementia of Alzheimer type
14. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations
15. Cholinesterase inhibition: Complexities in interpretation
16. Cholinergic markers in elderly patients with early signs of Alzheimer disease
17. Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited